Linus Health to Present New Research Findings at Leading Alzheimer’s and Parkinson’s Conference
AD/PD™ 2025 to feature presentations on Linus Health's digital cognitive health assessments, plus attendees can learn more about company's recent...
Neuroscience
Axsome Therapeutics Announces FOCUS Phase 3 Trial of Solriamfetol in Adults with Attention Deficit Hyperactivity Disorder (ADHD) Achieves Primary Endpoint
Demonstrated substantial and statistically significant improvement in ADHD symptoms as measured by the AISRS total score compared to placebo (p=0.039,...
ProMIS Neurosciences Showcases Preclinical Data on Platform-Derived Antibody and Vaccines for Neurodegenerative Diseases at Alzheimer’s Disease/Parkinson’s Disease 2025 International Conference
Multiple datasets support continued development of ProMIS’ antibody therapeutics and vaccines that selectively target toxic misfolded proteins to treat neurodegenerative...
Johnson & Johnson Increases U.S. Investment to More than $55 Billion Over the Next Four Years
Investment builds on almost 140-year legacy of improving and saving lives and supporting American jobs Includes four planned new manufacturing...
Life Sciences and Nutrition Luminary Dr. Rob Sinnott joins Radicle Science as Senior Strategic Advisor
Addition Bolsters Healthtech Pioneer's Innovation Trajectory; Accelerates Growth, Diversifies Offerings and Expands Global Reach SAN DIEGO, March 20, 2025 /PRNewswire/...
brain.space ANNOUNCES $11M SERIES A FUNDING ROUND TO ACCELERATE DESIGN OF BRAIN DATA-DRIVEN MENTAL MODELING
Neurotechnology Pioneer Utilizes Standardized Brain Data to Predict Human Behavior, Enhance Digital Systems across Consumer, Health, Defense, and Aerospace TEL...
Psyence Biomed Further Strengthens Scientific Advisory Board with Appointment of Dr. Dan J. Stein
Appointment adds significant clinical and scientific expertise in the field of psychedelic-based therapiesNew York, New York--(Newsfile Corp. - March 18,...
Octane’s First ‘Neuro Tech Forum’: Cutting-Edge Innovations and Global Leaders Converge in Newport Beach, April 2025
Southern California's Leading Medtech Octane's Premier Event Unites Global Stakeholders and Spotlights Innovations in Neuroscience and Technology for a Day...
VAS101, a Novel Curcumin Transdermal Formulation, Reverses Some Clinical Hallmarks of Aging
SUMMIT, N.J., March 17, 2025 /PRNewswire/ -- In a new study published in the journal GeroScience, VAS101 (Vasceptor®), a novel...
Clario announces acquisition of imaging provider NeuroRx
Acquisition further builds on Clario's neuroscience expertise and capabilities PHILADELPHIA, March 17, 2025 /PRNewswire/ -- Clario, a leading provider of...
InTandem Capital Partners Announces Strategic Investment in Clinilabs
NEW YORK--(BUSINESS WIRE)--InTandem Capital Partners (“InTandem Capital” or the “Firm”), a healthcare services-focused private equity firm, announced today that it...
Clene Demonstrates Strengthened ALS Survival Benefit with CNM-Au8® Treatment
New Cross-Regimen Analysis of HEALEY ALS Platform Trial Shows Significant Survival AdvantageSALT LAKE CITY, March 12, 2025 (GLOBE NEWSWIRE) --...
Angelini Ventures leads €10 million Series A financing in Vantis, a Digital Care Innovation company
Strategic investment in digital health solutions addressing critical challenges in primary care and chronic disease management Rome, Italy, 12 March...
Ipsen appoints Olivia Brown as Executive Vice-President, Global Head of Neurotoxins
PARIS, FRANCE, March 12th, 2025 - Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty care-driven company, announced today the appointment...
openRxiv Launch to Sustain and Expand Preprint Sharing in Life and Health Sciences
DAVIS, Calif., March 11, 2025 /PRNewswire/ -- openRxiv has officially launched as an independent nonprofit to oversee bioRxiv and medRxiv,...
BrainsWay Reports Fourth Quarter and Full Year 2024 Financial Results and Operational Highlights
Achieved record quarterly sales of $11.4 million in Q4 2024, an increase of 27% compared with Q4 2023 Full year...
ProMIS Neurosciences to Participate in the 37th Annual Roth Conference
CAMBRIDGE, Massachusetts, March 11, 2025 (GLOBE NEWSWIRE) -- ProMIS Neurosciences, Inc. (Nasdaq: PMN), a clinical-stage biotechnology company focused on the...
BioXcel Therapeutics Strengthens Cash Position to Advance SERENITY At-Home Pivotal Phase 3 Safety Trial for Acute Treatment of Agitation Associated with Bipolar Disorders or Schizophrenia
Topline data expected in second half of 2025 to support potential sNDA submission for label expansion of IGALMI® in the home...
Clario Enters into Definitive Agreement to Acquire WCG’s eCOA Business
Acquisition of WCG's electronic clinical outcome assessments (eCOA) business will expand Clario's scientific expertise and offerings in neuroscience PHILADELPHIA, March 10,...
DR. DEEPAK CHOPRA WITH CYBERHUMAN.AI AND ELEMIND ANNOUNCE PARTNERSHIP TO REVOLUTIONIZE SLEEP
Introducing "21 Days of Restful Sleep with Dr. Deepak Chopra & Elemind"—A New Ritual Combining Guided Meditations and Pioneering Wearable...